MediPoint: Breast Cancer Imaging - APAC Analysis and Market Forecasts

Summary

Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundation for increasing survival rates and diagnostic imaging is the most widely used technique to achieve early detection, making diagnostic imaging a cornerstone of breast cancer control.

The APAC breast cancer imaging market is a mature industry with complex dynamics and it is essential to examine the market opportunities and barriers that are specific to this region. This report provides an in-depth review of the evolving technologies and the regulatory landscape of the breast cancer screening market in APAC.

Scope

- An overview of breast cancer, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized APAC Breast cancer imaging market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for Breast cancer imaging
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Breast cancer imaging sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as radiologists

Reasons to buy

- Understand the trends shaping and driving APAC Breast cancer imaging Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in APAC Breast cancer imaging Market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in APAC Breast cancer imaging market landscape? Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
1 Table of Contents 5


2 Introduction 21
2.1 Catalyst 21
3 Disease Overview 22
3.1 Anatomy and Physiology of the Breast 22
3.2 Pathophysiology of Breast Cancer 23
3.3 Detection of Breast Cancer 23
3.4 Types of Breast Cancer 24
3.5 Clinical Presentation 26
3.6 Clinical Outcomes 27
3.6.1 Assessment Procedure 27
3.6.2 Screening Guidelines 30
3.7 Epidemiology of Breast Cancer 32
3.8 Economic Impact of Breast Cancer Imaging 35
4 Imaging Techniques 36
4.1 Mammography 36
4.1.1 Overview 36
4.1.2 Types of Mammography 38
4.2 Non-Mammographic Techniques 43
4.2.1 Breast Ultrasound Imaging 43
4.2.2 Breast Magnetic Resonance Imaging 44
4.3 Comparison of Mammography, Ultrasound, and MRI 45
4.4 Alternative Breast Imaging Techniques 46
4.4.1 Nuclear Imaging Techniques 47
4.4.2 Computed Tomography 48
4.4.3 Optical Breast Imaging 49
4.4.4 Electric Impedance-Based Techniques 49
4.4.5 Thermography 50
4.4.6 Elastography 50
4.4.7 Ductogram 50
5 Competitive Assessment 51
5.1 Overview 51
5.2 Film Screen Mammography 52
5.2.1 Performa (GE Healthcare) 52
5.2.2 Alpha RT/Alpha ST (GE Healthcare) 55
5.2.3 MAMMOMAT 1000 (Siemens Healthcare) 58
5.2.4 MAMMOMAT 3000 Nova (Siemens Healthcare) 60
5.2.5 M-IV/M-IV Platinum (Hologic) 62
5.2.6 MammoDiagnost (Philips Healthcare) 64
5.2.7 Planmed Nuance Classic (Planmed) 66
5.2.8 Planmed Sophie Classic (Planmed) 68
5.2.9 Analog Giotto Image (Internazionale Medico Scientifica) 70
5.2.10 HAWK-2M (Hologic) 72
5.2.11 MGU-1000A (Toshiba Medical Systems) 74
5.3 CR Mammography 76
5.3.1 Fuji Computed Radiography Mammography Suite (FCRMS) (Fujifilm Medical Systems) 76
5.3.2 KODAK DirectView (Carestream Health) 78
5.3.3 Xpress CR System (Konica Minolta) 80
5.3.4 REGIUS PureView (Konica Minolta) 82
5.3.5 Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) (Agfa Healthcare) 84
5.4 Full-Field Digital Mammography 86
5.4.1 Selenia Dimensions (Hologic) 87
5.4.2 Selenia (Hologic) 90
5.4.3 Selenia S (Hologic) 92
5.4.4 Selenia Performance (Hologic) 94
5.4.5 Senographe DS (GE Healthcare) 96
5.4.6 Senographe Essential (GE Healthcare) 98
5.4.7 Senographe Care (GE Healthcare) 100
5.4.8 SenoBright CESM (GE Healthcare) 102
5.4.9 MAMMOMAT Inspiration (Siemens Healthcare) 104
5.4.10 Aspire HD (US)/Amulet (Outside the US) (Fujifilm) 106
5.4.11 MammoDiagnost DR (Philips Healthcare) 108
5.4.12 MicroDose (Philips Healthcare) 110
5.4.13 Giotto Image 3D/3DL (Internazionale Medico Scientifica) 112
5.4.14 Planmed Nuance/Nuance Excel (Planmed) 114
5.4.15 Fairy DR (Allengers Medical Systems) 116
5.4.16 Serenity 118
5.5 3D Mammography 120
5.5.1 Selenia Dimensions 3D System (Hologic) 120
5.5.2 GE Breast Tomosynthesis (GE Healthcare) 122
5.5.3 True 3D Breast Tomosynthesis (Siemens Healthcare) 124
5.5.4 Giotto Tomo (Internazionale Medico Scientifica) 126
5.5.5 FUJIFILM 3Dimensional Mammography (Fujifilm) 128
5.6 Breast Ultrasound Imaging 130
5.6.1 somo.v Automated Breast Ultrasound (ABUS) (GE Healthcare) 130
5.6.2 SonoCine AWBUS (SonoCine) 132
5.6.3 ACUSON S2000 ABVS (Siemens Healthcare) 134
5.6.4 Terason t3200 Ultrasound System Breast Series (Terason Ultrasound) 136
5.7 Breast MRI 138
5.7.1 Aurora 1.5T Dedicated Breast MRI System (Aurora Imaging Technology) 138
5.8 Other Breast Imaging Techniques 140
5.8.1 PEM Flex Solo II (Naviscan) 140
5.8.2 Computerized Tomography Laser Mammography (CTLM) Model 1020 (Imaging Diagnostic Systems) 142
5.8.3 Dilon 6800/Dilon 6800 Acella (Dilon Diagnostics) 144
5.8.4 LumaGEM (Gamma Medica) 146
5.8.5 Discovery NM 750b (GE Healthcare) 148
6 Unmet Needs 150
6.1 Lower Radiation Dose 150
6.2 Increase Patient Comfort 152
6.3 Reduce False-Positives and False-Negatives 154
6.4 Loss of Sensitivity of Mammography in Dense Breasts 156
6.5 Unreliable Mammograms in Surgically-Operated Breasts and Breasts with Implants 159
6.6 Commitment to Training 160
7 Pipeline Products 163
7.1 Breast Cancer Imaging Pipeline Products Overview 163
7.2 MAMMOMAT Inspiration PRIME Edition 164
7.2.1 Overview 164
7.2.2 SWOT Analysis 164
7.3 MicroDose SI 165
7.3.1 Overview 165
7.3.2 SWOT Analysis 165
7.4 Selenia Dimensions 2D Contrast-Enhanced Digital Mammography (CEDM) 166
7.4.1 Overview 166
7.4.2 SWOT Analysis 166
7.5 SenoCase 167
7.5.1 Overview 167
7.5.2 SWOT Analysis 168
7.6 Electrical Mammogram 169
7.6.1 Overview 169
7.6.2 SWOT Analysis 169
8 Industry Overview 170
8.1 Purchasing Cycle 170
8.1.1 Product Life Cycle 170
8.1.2 Cost Effectiveness in Screening Settings 172
8.1.3 Cost-Effectiveness in Diagnostic Settings 172
8.2 Market Access 173
8.2.1 Purchasing Decisions 173
8.2.2 Regulatory Process 174
8.3 Quality Assurance 175
8.3.1 Japan 175
8.3.2 China and India 175
8.4 Adoption of New Technologies 176
8.4.1 Influence of Clinical Trials Results 176
8.4.2 Reimbursement 177
8.4.3 Economic Resources 177
8.4.4 Low Breast Cancer Incidence and Absence of a National Screening Program 177
8.4.5 Competitive Advantage 178
8.5 Current Reimbursement Trends in APAC 179
8.5.1 Japan 179
8.5.2 China 179
8.5.3 India 180
8.6 Trends in Detector Technology for Digital Mammography 180
8.7 Evolving Scatter-Removal Mechanisms 184
8.8 Overdiagnosis 186
8.9 Malpractice Litigations 187
8.10 Mergers and Acquisitions/Key Partnerships 188
8.10.1 GE Healthcare Acquires U-Systems 188
8.10.2 Koninklijke Philips Electronics Acquires MicroDose Mammography from Sectra 188
8.10.3 Hologic Acquires Beijing Healthcome Technology 188
8.10.4 Hologic Acquires Sentinelle Medica 188
8.10.5 Koninklijke Philips Electronics Acquires Shanghai Apex Electronics Technology 189
8.10.6 Fujifilm Medical Systems acquired FUJIFILM-RU 189
8.10.7 Other Key Events 189
9 Current and Future Players 190
9.1 Overview 190
9.2 Trends in Corporate Strategy 191
9.3 Company Profiles 192
9.3.1 GE Healthcare 192
9.3.2 Hologic 194
9.3.3 Siemens 196
9.3.4 Koninklijke Philips Electronics 197
9.3.5 Fujifilm Medical Systems 199
9.3.6 Internazionale Medico Scientifica (IMS) 200
9.3.7 Planmed 201
9.3.8 Konica Minolta Medical Imaging 202
9.3.9 Agfa Healthcare 203
9.3.10 Carestream Health 204
9.3.11 SonoCine 205
9.3.12 Aurora Imaging Technology 206
9.3.13 Imaging Diagnostic Systems 207
9.3.14 Naviscan 208
9.3.15 Dilon Diagnostics 209
9.3.16 Gamma Medica 210
9.3.17 Allengers Medical Systems 211
10 Market Drivers and Opportunities 212
10.1 Market Drivers 212
10.1.1 Increase in the Incidence of Breast Cancer 212
10.1.2 Increased Awareness of the Benefits of Screening 212
10.1.3 Increased Breast Cancer Incidence Due to an Aging Population 213
10.1.4 New Technologies to Drive Market Growth 213
10.1.5 Adoption of Digital Mammography Units in APAC 214
10.2 Opportunities 215
10.2.1 Emerging Economies Promise Future Growth 215
10.2.2 Invest in Emerging Technologies 216
10.2.3 Product Improvement 217
10.3 Market Barriers 218
10.3.1 Shortage of Dedicated Mammography Professionals 218
10.3.2 Reduced Hospital Budgets 218
10.3.3 Refurbished Equipment Sales 219
10.3.4 Reimbursement 220
10.3.5 Substitutes 220
11 Country Outlooks and Forecasts 221
11.1 Major Markets Overview 221
11.2 Japan 223
11.2.1 Japan Market Analysis 223
11.3 China 224
11.3.1 China Market Analysis 224
11.4 India 226
11.4.1 India Market Analysis 226
12 Appendix 228
12.1 Bibliography 228
12.2 Abbreviations 255
12.3 Report Methodology 260
12.3.1 Overview 260
12.3.2 Coverage 260
12.3.3 Secondary Research 260
12.3.4 Forecast Methodology 261
12.4 Physicians and Specialists Included in this Study 262
12.5 Primary Research 263
12.6 Physician Survey 263
12.7 About the Authors 264
12.7.1 Analysts 264
12.7.2 Global Head of Healthcare 265
12.8 Definitions 266
12.9 About MediPoint 267
12.10 About GlobalData 267
12.11 Contact Us 267
12.12 Disclaimer 267

1.1 List of Tables
Table 1: Breast Cancer Types, Including Diagnostic Procedures 25
Table 2: ACR Breast Imaging Reporting and Database System (BI-RADS) 27
Table 3: Selected Breast Cancer Incidence Rates of India and China, 2002 33
Table 4: Comparison of Mammography, Ultrasound, and MRI for Breast Imaging 45
Table 5: Performa Product Profile 53
Table 6: Performa SWOT Analysis 54
Table 7: Alpha RT/Alpha ST Product Profile 56
Table 8: Alpha RT/Alpha ST SWOT Analysis 57
Table 9: MAMMOMAT 1000 Product Profile 58
Table 10: MAMMOMAT 1000 SWOT Analysis 59
Table 11: MAMMOMAT 3000 Nova Product Profile 61
Table 12: MAMMOMAT 3000 Nova SWOT Analysis 61
Table 13: M-IV/M-IV Platinum Product Profile 63
Table 14: M-IV/M-IV Platinum SWOT Analysis 63
Table 15: MammoDiagnost Product Profile 65
Table 16: MammoDiagnost SWOT Analysis 65
Table 17: Planmed Nuance Classic Product Profile 67
Table 18: Planmed Nuance Classic SWOT Analysis 67
Table 19: Planmed Sophie Classic Product Profile 69
Table 20: Planmed Sophie Classic SWOT Analysis 69
Table 21: Analog Giotto Image Product Profile 71
Table 22: Analog Giotto Image SWOT Analysis 71
Table 23: HAWK-2M Product Profile 73
Table 24: HAWK-2M SWOT Analysis 73
Table 25: MGU-1000A Product Profile 75
Table 26: MGU-1000A SWOT Analysis 75
Table 27: Fuji Computed Radiography Mammography Suite (FCRMS) Product Profile 77
Table 28: Fuji Computed Radiography Mammography Suite (FCRMS) SWOT Analysis 77
Table 29: KODAK DirectView CR System Product Profile 79
Table 30: KODAK DirectView CR System SWOT Analysis 79
Table 31: Xpress CR System Product Profile 80
Table 32: Xpress CR System SWOT Analysis 81
Table 33: REGIUS PureView Product Profile 83
Table 34: REGIUS PureView SWOT Analysis 83
Table 35: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) Product Profile 85
Table 36: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) SWOT Analysis 85
Table 37: FFDM SWOT Analysis 86
Table 38: Selenia Dimensions Product Profile 88
Table 39: Selenia Dimensions SWOT Analysis 89
Table 40: Selenia Product Profile 91
Table 41: Selenia SWOT Analysis 91
Table 42: Selenia S Product Profile 93
Table 43: Selenia S SWOT Analysis 93
Table 44: Selenia Performance Product Profile 95
Table 45: Selenia Performance SWOT Analysis 95
Table 46: Senographe DS Product Profile 97
Table 47: Senographe DS SWOT Analysis 97
Table 48: Senographe Essential/Senographe Essential E Product Profile 99
Table 49: Senographe Essential SWOT Analysis 99
Table 50: Senographe Care Product Profile 101
Table 51: Senographe Care SWOT Analysis 101
Table 52: SenoBright CESM Product Profile 103
Table 53: SenoBright CESM SWOT Analysis 103
Table 54: MAMMOMAT Inspiration Product Profile 105
Table 55: MAMMOMAT Inspiration SWOT Analysis 105
Table 56: Aspire HD/Amulet Product Profile 107
Table 57: Aspire HD/Amulet SWOT Analysis 107
Table 58: MammoDiagnost DR Product Profile 108
Table 59: MammoDiagnost DR SWOT Analysis 109
Table 60: MicroDose Product Profile 111
Table 61: MicroDose SWOT Analysis 111
Table 62: Giotto Image 3D/3DL Product Profile 113
Table 63: Giotto Image 3D/3DL SWOT Analysis 113
Table 64: Planmed Nuance/Nuance Excel Product Profile 115
Table 65: Planmed Nuance/Nuance Excel SWOT Analysis 115
Table 66: Fairy DR Product Profile 117
Table 67: Fairy DR SWOT Analysis 117
Table 68: Serenity Product Profile 119
Table 69: Serenity SWOT Analysis 119
Table 70: Selenia Dimensions 3D System Product Profile 121
Table 71: Selenia Dimensions SWOT Analysis 121
Table 72: GE Breast Tomosynthesis Product Profile 123
Table 73: GE Breast Tomosynthesis SWOT Analysis 123
Table 74: True 3D Breast Tomosynthesis Product Profile 125
Table 75: True 3D Breast Tomosynthesis SWOT Analysis 125
Table 76: Giotto Tomo Product Profile 127
Table 77: Giotto Tomo SWOT Analysis 127
Table 78: FUJIFILM 3Dimensional Mammography Product Profile 129
Table 79: FUJIFILM 3Dimensional Mammography SWOT Analysis 129
Table 80: somo.v ABUS Product Profile 131
Table 81: somo.v ABUS SWOT Analysis 131
Table 82: SonoCine AWBUS Product Profile 133
Table 83: SonoCine AWBUS SWOT Analysis 133
Table 84: ACUSON S2000 ABVS Product Profile 135
Table 85: Acuson S2000 ABVS SWOT Analysis 135
Table 86: Terason t3200 Ultrasound System Breast Series Product Profile 137
Table 87: Terason t3200 Ultrasound System Breast Series SWOT Analysis 137
Table 88: Aurora 1.5T Dedicated Breast MRI System Product Profile 139
Table 89: Aurora 1.5T Dedicated Breast SWOT Analysis 139
Table 90: PEM Flex Solo II Product Profile 141
Table 91: PEM Flex Solo II SWOT Analysis 141
Table 92: Computerized Tomography Laser Mammography (CTLM) Model 1020 Product Profile 143
Table 93: Computerized Tomography Laser Mammography (CTLM) Model 1020 SWOT Analysis 143
Table 94: Dilon 6800/Dilon 6800 Acella Product Profile 145
Table 95: Dilon 6800/Dilon 6800 Acella SWOT Analysis 145
Table 96: LumaGEM Product Profile 147
Table 97: LumaGEM SWOT Analysis 147
Table 98: Discovery NM 750b Product Profile 149
Table 99: Discovery NM 750b SWOT Analysis 149
Table 100: Breast Cancer Imaging Pipeline Products 163
Table 101: MAMMOMAT Inspiration PRIME Edition SWOT Analysis 164
Table 102: Philips MicroDose SI SWOT Analysis 165
Table 103: Selenia Dimensions 2D Contrast Imaging SWOT Analysis 166
Table 104: SenoCase SWOT Analysis 168
Table 105: Electrical Mammogram SWOT Analysis 169
Table 106: Other Key Events in the Breast Cancer Imaging Market 189
Table 107: GE Healthcare SWOT Analysis, 2013 193
Table 108: Hologic SWOT Analysis, 2013 195
Table 109: Siemens SWOT Analysis, 2013 196
Table 110: Koninklijke Philips Electronics SWOT Analysis, 2013 198
Table 111: Fujifilm Medical Systems, SWOT Analysis, 2013 199
Table 112: Internazionale Medico Scientifica SWOT Analysis, 2013 200
Table 113: Planmed, SWOT Analysis, 2013 201
Table 114: Konica Minolta Medical Imaging, SWOT Analysis, 2013 202
Table 115: Agfa Healthcare, SWOT Analysis, 2013 203
Table 116: Carestream Health, SWOT Analysis, 2013 204
Table 117: SonoCine, SWOT Analysis, 2013 205
Table 118: Aurora Imaging Technology, SWOT Analysis, 2013 206
Table 119: Imaging Diagnostic Systems, SWOT Analysis, 2013 208
Table 120: Naviscan, SWOT Analysis, 2013 208
Table 121: Dilon Diagnostics, SWOT Analysis, 2013 209
Table 122: Gamma Medica, SWOT Analysis, 2013 210
Table 123: Allengers Medical Systems, SWOT Analysis, 2013 211
Table 124: Major Events Affecting the APAC Breast Cancer Imaging Market, 2011- 2017 221
Table 125: Sales Forecasts for Breast Cancer Imaging in the APAC Markets, 2009-2018 221
Table 126: Sales Forecasts for Breast Cancer Imaging in Japan, 2009-2018 223
Table 127: Sales Forecasts for Breast Cancer Imaging in China, 2009-2018 224
Table 128: Sales Forecasts for Breast Cancer Imaging in India, 2009-2018 226
Table 129: Physicians Surveyed, By Country 263

1.2 List of Figures
Figure 1: Anatomy of the Breast 22
Figure 2: Breast Cancer Screening, Diagnostic Evaluation, and Follow-Up 28
Figure 3: Percentage Use of Ultrasound Imaging and MRI for Breast Cancer Screening and Follow-Up, 2009-2016 29
Figure 4: Breast Cancer Risk Factors 32
Figure 5: Breast Cancer Incidence in APAC, CAGR, 2012-2018 33
Figure 6: Projected Incidence of Breast Cancer in APAC, 2012-2018 34
Figure 7: Comparison Between Digital (FFDM) and Analog (FSM) Mammography 39
Figure 8: Use of Alternative Breast Imaging Modalities, 2009-2016 46
Figure 9: Performa 53
Figure 10: Alpha RT 55
Figure 11: Alpha ST 56
Figure 12: MAMMOMAT 1000 58
Figure 13: MAMMOMAT 3000 Nova 60
Figure 14: M-IV/M-IV Platinum 62
Figure 15: MammoDiagnost 64
Figure 16: Planmed Nuance Classic 66
Figure 17: Planmed Sophie Classic 68
Figure 18: Analog Giotto Image 70
Figure 19: HAWK-2M 72
Figure 20: MGU-1000A 74
Figure 21: Aspire CRm 77
Figure 22: KODAK DirectView CR System 78
Figure 23: Xpress CR System 80
Figure 24: REGIUS PureView Type M 82
Figure 25: DX-M Digitizer 84
Figure 26: Selenia Dimensions 87
Figure 27: Selenia 90
Figure 28: Selenia S 92
Figure 29: Selenia Performance 94
Figure 30: Senographe DS 96
Figure 31: Senographe Essential 98
Figure 32: Senographe Care 100
Figure 33: SenoBright CESM* 102
Figure 34: MAMMOMAT Inspiration 104
Figure 35: Aspire HD 106
Figure 36: MammoDiagnost DR 108
Figure 37: MicroDose 110
Figure 38: Giotto Image 3D/3DL 112
Figure 39: Planmed Nuance/Nuance Excel 114
Figure 40: Fairy DR 116
Figure 41: Serenity 118
Figure 42: Selenia Dimensions 2D System 120
Figure 43: Senographe Essential 122
Figure 44: True 3D Breast Tomosynthesis* 124
Figure 45: Giotto Tomo 126
Figure 46: Fujifilm 3D Mammography Viewer 128
Figure 47: somo.v ABUS 130
Figure 48: SonoCine AWBUS 132
Figure 49: ACUSON S2000 ABVS 134
Figure 50: Terason t3200 Ultrasound System Breast Series 136
Figure 51: Aurora 1.5T Dedicated Breast MRI System 138
Figure 52: PEM Flex Solo II 140
Figure 53: CTLM Model 1020 142
Figure 54: Dilon 6800 Acella 144
Figure 55: Dilon 6800 145
Figure 56: LumaGEM 146
Figure 57: Discovery NM 750b 148
Figure 58: Percentage of False-Positive, False-Negative and Accurate Breast Cancer Diagnoses from 2011-2012 155
Figure 59: SenoCase 167
Figure 60: Product Life Cycle 171
Figure 61: Detector Evolution 180
Figure 62: Comparison Between a Typical Direct Conversion Detector and a Direct Optical Switching Detector 182
Figure 63: Photon-Counting Detector Technology 183
Figure 64: Linear and High Transmission Cellular Grids 185
Figure 65: Sales Forecasts for Breast Cancer Imaging in APAC, 2009-2018 221
Figure 66: APAC Breast Cancer Imaging Market Revenue, by Region, 2011 and 2018 222
Figure 67: Sales Forecasts for Breast Cancer Imaging in Japan, 2009-2018 223
Figure 68: Sales Forecasts for Breast Cancer Imaging in China, 2009-2018 224
Figure 69: Sales Forecasts for Breast Cancer Imaging in India, 2009-2018 226

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global MRI Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global MRI Market 2014: Strategic Assessments of Leading Suppliers

  • $ 7 400
  • Industry report
  • August 2014
  • by Venture Planning Group

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.